Morgan Stanley Initiates Coverage On Ardent Health Partners with Overweight Rating, Announces Price Target of $27
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley has initiated coverage on Ardent Health Partners (NYSE:ARDT) with an Overweight rating and a price target of $27.
August 12, 2024 | 9:37 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has initiated coverage on Ardent Health Partners with an Overweight rating and a price target of $27.
The initiation of coverage with an Overweight rating and a specific price target of $27 by a major financial institution like Morgan Stanley is likely to positively impact the stock price of Ardent Health Partners in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100